| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5993856 | PADAGIS US | Pharmaceutical preparations and methods for their administration |
Nov, 2017
(6 years ago) | |
Butoconazole Nitrate is owned by Padagis Us.
Butoconazole Nitrate contains Butoconazole Nitrate.
Butoconazole Nitrate has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Butoconazole Nitrate are:
- US5993856
Butoconazole Nitrate was authorised for market use on 07 February, 1997.
Butoconazole Nitrate is available in cream;vaginal dosage forms.
Butoconazole Nitrate can be used as method of treating a vaginal fungal infection in a female human.
The generics of Butoconazole Nitrate are possible to be released after 17 November, 2017.
Drugs and Companies using BUTOCONAZOLE NITRATE ingredient
Market Authorisation Date: 07 February, 1997
Treatment: Method of treating a vaginal fungal infection in a female human
Dosage: CREAM;VAGINAL
BUTOCONAZOLE NITRATE family patents
